Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Oct;82(19):6431–6434. doi: 10.1073/pnas.82.19.6431

Inhibition of chymotrypsin by heparin cofactor II.

F C Church, C M Noyes, M J Griffith
PMCID: PMC390730  PMID: 3863104

Abstract

Human heparin cofactor II is a plasma protein that is known to inhibit thrombin. The rate of thrombin inhibition by heparin cofactor II is accelerated (greater than or equal to 1000-fold) in the presence of the glycosaminoglycans, heparin and dermatan sulfate. We have found that chymotrypsin A alpha is also inhibited by heparin cofactor II with a second-order rate constant value of 1.8 X 10(6) M-1 X min-1 at pH 8.0 and 25 degrees C. However, there was no measurable effect of heparin or dermatan sulfate on the rate of chymotrypsin inhibition. Arginine-modified heparin cofactor II showed a comparable percentage loss of both antichymotrypsin and antithrombin activities. Heparin cofactor II and chymotrypsin formed a stable complex with a Mr value near 90,000 when analyzed by NaDodSO4/polyacrylamide gel electrophoresis; this suggests a 1:1 reaction stoichiometry. The chymotrypsin cleavage site in heparin cofactor II was the same as that for thrombin, and primary structure analysis of the inhibitor showed a P'1-P'8 sequence of Ser-Thr-Gln-Val-Arg-Phe-Thr-Val ... . The results indicate that, in contrast to alpha 1-antichymotrypsin, which does not inhibit trypsin-like enzymes, including thrombin, heparin cofactor II can effectively inhibit both thrombin and chymotrypsin.

Full text

PDF
6431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980 May 10;255(9):3931–3934. [PubMed] [Google Scholar]
  2. Björk I., Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem. 1982 Oct 29;48(3):161–182. doi: 10.1007/BF00421226. [DOI] [PubMed] [Google Scholar]
  3. Briginshaw G. F., Shanberge J. N. Identification of two distinct heparin cofactors in human plasma. II. Inhibition of thrombin and activated factor X. Thromb Res. 1974 Mar;4(3):463–477. doi: 10.1016/0049-3848(74)90081-4. [DOI] [PubMed] [Google Scholar]
  4. Briginshaw G. F., Shanberge J. N. Identification of two distinct heparin cofactors in human plasma. Separation and partial purification. Arch Biochem Biophys. 1974 Apr 2;161(2):683–690. doi: 10.1016/0003-9861(74)90354-3. [DOI] [PubMed] [Google Scholar]
  5. Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
  6. Chandra T., Stackhouse R., Kidd V. J., Robson K. J., Woo S. L. Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III. Biochemistry. 1983 Oct 25;22(22):5055–5061. doi: 10.1021/bi00291a001. [DOI] [PubMed] [Google Scholar]
  7. Chandra T., Stackhouse R., Kidd V. J., Woo S. L. Isolation and sequence characterization of a cDNA clone of human antithrombin III. Proc Natl Acad Sci U S A. 1983 Apr;80(7):1845–1848. doi: 10.1073/pnas.80.7.1845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Church F. C., Griffith M. J. Evidence for essential lysines in heparin cofactor II. Biochem Biophys Res Commun. 1984 Nov 14;124(3):745–751. doi: 10.1016/0006-291x(84)91021-0. [DOI] [PubMed] [Google Scholar]
  9. DelMar E. G., Largman C., Brodrick J. W., Geokas M. C. A sensitive new substrate for chymotrypsin. Anal Biochem. 1979 Nov 1;99(2):316–320. doi: 10.1016/s0003-2697(79)80013-5. [DOI] [PubMed] [Google Scholar]
  10. Doolittle R. F. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science. 1983 Oct 28;222(4622):417–419. doi: 10.1126/science.6604942. [DOI] [PubMed] [Google Scholar]
  11. Downing M. R., Bloom J. W., Mann K. G. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry. 1978 Jun 27;17(13):2649–2653. doi: 10.1021/bi00606a030. [DOI] [PubMed] [Google Scholar]
  12. Edman P., Begg G. A protein sequenator. Eur J Biochem. 1967 Mar;1(1):80–91. doi: 10.1007/978-3-662-25813-2_14. [DOI] [PubMed] [Google Scholar]
  13. Elmore D. T., Smyth J. J. A new method for determining the absolute molarity of solutions of trypsin and chymotrypsin by using p-nitrophenyl N2-acetyl-N1-benzylcarbazate. Biochem J. 1968 Mar;107(1):103–107. doi: 10.1042/bj1070103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Everitt M. T., Neurath H. Purification and partial characterization of an alpha-chymotrypsin-like protease of rat peritoneal mast cells. Biochimie. 1979;61(5-6):653–662. doi: 10.1016/s0300-9084(79)80163-7. [DOI] [PubMed] [Google Scholar]
  15. Griffith M. J., Carraway T., White G. C., Dombrose F. A. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma. Blood. 1983 Jan;61(1):111–118. [PubMed] [Google Scholar]
  16. Griffith M. J. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5460–5464. doi: 10.1073/pnas.80.18.5460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Griffith M. J., Noyes C. M., Church F. C. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. J Biol Chem. 1985 Feb 25;260(4):2218–2225. [PubMed] [Google Scholar]
  18. Gupton B. F., Carroll D. L., Tuhy P. M., Kam C. M., Powers J. C. Reaction of azapeptides with chymotrypsin-like enzymes. New inhibitors and active site titrants for chymotrypsin A alpha, subtilisin BPN', subtilisin Carlsberg, and human leukocyte cathepsin G. J Biol Chem. 1984 Apr 10;259(7):4279–4287. [PubMed] [Google Scholar]
  19. Hunt L. T., Dayhoff M. O. A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor. Biochem Biophys Res Commun. 1980 Jul 31;95(2):864–871. doi: 10.1016/0006-291x(80)90867-0. [DOI] [PubMed] [Google Scholar]
  20. Jörnvall H., Fish W. W., Björk I. The thrombin cleavage site in bovine antithrombin. FEBS Lett. 1979 Oct 15;106(2):358–362. doi: 10.1016/0014-5793(79)80532-3. [DOI] [PubMed] [Google Scholar]
  21. KITZ R., WILSON I. B. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem. 1962 Oct;237:3245–3249. [PubMed] [Google Scholar]
  22. Kurachi K., Chandra T., Degen S. J., White T. T., Marchioro T. L., Woo S. L., Davie E. W. Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6826–6830. doi: 10.1073/pnas.78.11.6826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LEVY H. M., LEBER P. D., RYAN E. M. INACTIVATION OF MYOSIN BY 2,4-DINITROPHENOL AND PROTECTION BY ADENOSINE TRIPHOSPHATE AND OTHER PHOSPHATE COMPOUNDS. J Biol Chem. 1963 Nov;238:3654–3659. [PubMed] [Google Scholar]
  24. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  25. Laskowski M., Jr, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem. 1980;49:593–626. doi: 10.1146/annurev.bi.49.070180.003113. [DOI] [PubMed] [Google Scholar]
  26. McReynolds L., O'Malley B. W., Nisbet A. D., Fothergill J. E., Givol D., Fields S., Robertson M., Brownlee G. G. Sequence of chicken ovalbumin mRNA. Nature. 1978 Jun 29;273(5665):723–728. doi: 10.1038/273723a0. [DOI] [PubMed] [Google Scholar]
  27. Morii M., Travis J. Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin. J Biol Chem. 1983 Nov 10;258(21):12749–12752. [PubMed] [Google Scholar]
  28. Parker K. A., Tollefsen D. M. The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. J Biol Chem. 1985 Mar 25;260(6):3501–3505. [PubMed] [Google Scholar]
  29. Prochownik E. V., Markham A. F., Orkin S. H. Isolation of a cDNA clone for human antithrombin III. J Biol Chem. 1983 Jul 10;258(13):8389–8394. [PubMed] [Google Scholar]
  30. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 1967 Apr 20;27(2):157–162. doi: 10.1016/s0006-291x(67)80055-x. [DOI] [PubMed] [Google Scholar]
  31. Schechter N. M., Fräki J. E., Geesin J. C., Lazarus G. S. Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. J Biol Chem. 1983 Mar 10;258(5):2973–2978. [PubMed] [Google Scholar]
  32. Schwartz L. B., Riedel C., Caulfield J. P., Wasserman S. I., Austen K. F. Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. J Immunol. 1981 Jun;126(6):2071–2078. [PubMed] [Google Scholar]
  33. Tarr G. E., Beecher J. F., Bell M., McKean D. J. Polyquarternary amines prevent peptide loss from sequenators. Anal Biochem. 1978 Feb;84(2):622–7?0=ENG. doi: 10.1016/0003-2697(78)90086-6. [DOI] [PubMed] [Google Scholar]
  34. Tollefsen D. M., Blank M. K. Detection of a new heparin-dependent inhibitor of thrombin in human plasma. J Clin Invest. 1981 Sep;68(3):589–596. doi: 10.1172/JCI110292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tollefsen D. M., Majerus D. W., Blank M. K. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem. 1982 Mar 10;257(5):2162–2169. [PubMed] [Google Scholar]
  36. Tollefsen D. M., Pestka C. A., Monafo W. J. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem. 1983 Jun 10;258(11):6713–6716. [PubMed] [Google Scholar]
  37. Tonnesen M. G., Klempner M. S., Austen K. F., Wintroub B. U. Identification of a human neutrophil angiotension II-generating protease as cathepsin G. J Clin Invest. 1982 Jan;69(1):25–30. doi: 10.1172/JCI110437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Travis J., Bowen J., Baugh R. Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry. 1978 Dec 26;17(26):5651–5656. doi: 10.1021/bi00619a011. [DOI] [PubMed] [Google Scholar]
  39. Travis J., Salvesen G. S. Human plasma proteinase inhibitors. Annu Rev Biochem. 1983;52:655–709. doi: 10.1146/annurev.bi.52.070183.003255. [DOI] [PubMed] [Google Scholar]
  40. Wintroub B. U., Schechter N. B., Lazarus G. S., Kaempfer C. E., Schwartz L. B. Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol. 1984 Nov;83(5):336–339. doi: 10.1111/1523-1747.ep12264144. [DOI] [PubMed] [Google Scholar]
  41. Woodbury R. G., Neurath H. Purification of an atypical mast cell protease and its levels in developing rats. Biochemistry. 1978 Oct 3;17(20):4298–4304. doi: 10.1021/bi00613a029. [DOI] [PubMed] [Google Scholar]
  42. Wunderwald P., Schrenk W. J., Port H. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin. Thromb Res. 1982 Feb 1;25(3):177–191. doi: 10.1016/0049-3848(82)90237-7. [DOI] [PubMed] [Google Scholar]
  43. Yoshida N., Everitt M. T., Neurath H., Woodbury R. G., Powers J. C. Substrate specificity of two chymotrypsin-like proteases from rat mast cells. Studies with peptide 4-nitroanilides and comparison with cathepsin G. Biochemistry. 1980 Dec 9;19(25):5799–5804. doi: 10.1021/bi00566a021. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES